A multiyear agreement signed by Blue Earth Diagnostics and PETNet Solutions will allow PETNet to scale up production and maintain distribution of Blue Earth's Axumin, or F-18 fluciclovine, as well as the commercial manufacturing and distribution of Blue Earth's investigational F-18 rhPSMA-7.3 tracer for prostate-specific membrane antigen imaging.
Blue Earth enters tracer supply deal with PETNet
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.